1255639-37-2Relevant articles and documents
NOVEL MODIFIED CURCUMINS AND THEIR USES
-
Page/Page column 50; 51, (2013/05/09)
This invention provides a compound having the structure (I) wherein α, β, A, B, and R1-R4 are defined herein. This invention also provides pharmaceutical compositions comprising the above compounds, a method of accelerating the healing of a wound, a method of inhibiting the activity and/or levels of a matrix metalloproteinase (MMP), a method of inhibiting the production of a cytokine in a population of cells, a method of inhibiting the production of a growth factor in a population of cells, and a method of inhibiting NFK-B activation in a population of cells.